Beranda › Kanker Paru Sel Kecil › Virginia › Arlington
Uji klinis Kanker Paru Sel Kecil di Arlington, VA
23 studi untuk Kanker Paru Sel Kecil mencari peserta di lokasi sekitar Arlington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Menerima pesertaFase 2
- Virginia Cancer Specialists - Fairfax /ID# 278298, Fairfax · 11 mi jauhnya
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Menerima pesertaFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Menerima pesertaFase 3
- Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax · 11 mi jauhnya
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Menerima pesertaFase 1/2
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 mi jauhnya
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Menerima pesertaFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Menerima pesertaFase 1/2
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Site 1002, Fairfax · 11 mi jauhnya
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Menerima pesertaFase 3
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Menerima pesertaFase 3
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Menerima pesertaFase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi jauhnya
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Menerima pesertaFase 3
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Menerima pesertaFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
Menerima pesertaFase 1
- Next Virginia, Fairfax · 11 mi jauhnya
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Menerima pesertaFase 2
- Virginia Cancer Specialists Research Institute, Fairfax · 11 mi jauhnya
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Clinical Trial Site, Fairfax · 11 mi jauhnya
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Menerima pesertaFase 1/2
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Menerima pesertaFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
A Study of LY4175408 in Participants With Advanced Cancer
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Research Site 102, Fairfax · 11 mi jauhnya
- Research Site 112, Fairfax · 11 mi jauhnya
Uji klinis Kanker Paru Sel Kecil di kota lain
- Houston, TX26 studi
- Boston, MA21 studi
- New York City, NY21 studi
- Nashville, TN20 studi
- Los Angeles, CA20 studi
- Orlando, FL15 studi
- Dallas, TX13 studi
- St. Louis, MO13 studi
- Cleveland, OH13 studi
- Detroit, MI12 studi
- Chicago, IL12 studi
- Washington, DC12 studi
Studi lain di Arlington
- Kanker Paru Non-Sel Kecil104 studi
- Kanker Metastatik53 studi
- Kanker Kolorektal52 studi
- Kanker (semua jenis)48 studi
- Kanker Payudara46 studi
- Kanker Ovarium46 studi
- Kanker Paru41 studi
- Kanker Endometrium39 studi
- Kanker Pankreas33 studi
- Karsinoma Sel Skuamosa Kepala dan Leher26 studi
- Kanker Payudara Triple-Negatif20 studi
- Kanker Lambung20 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.